Used as a key intermediate in the synthesis of pharmaceutical agents targeting neurological disorders. Its structure supports the development of compounds with activity against neurodegenerative diseases, particularly due to its ability to interact with central nervous system receptors. Commonly employed in research settings for designing inhibitors that modulate enzyme activity involved in neurotransmitter regulation. Also utilized in the preparation of photoprobes for studying receptor binding sites because of its photoaffinity labeling capabilities. Shows promise in medicinal chemistry for creating analogs with improved blood-brain barrier penetration.